Retrieval of immature oocytes after chemotherapy for Hodgkin's disease and prolonged ovarian down-regulation with gonadotropin-releasing hormone agonist

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 828.e1-828.e2

  Azem, Foad ^a   Hasson, Joseph ^a   Cohen, Tanya ^a   Shwartz, Tamar ^a   Mey Raz, Nava ^a   Almog, Beni ^a   Amit, Ami ^a   Ben Yosef, Dalit ^a  

^a LIS MATERNITY HOSPITAL   (Israel)

Author keywords

fertility preservation; GnRH agonist; Hodgkin's disease; in vitro maturation

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; ESTRADIOL; NORETHISTERONE ACETATE; TRIPTORELIN; VINBLASTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CRYOPRESERVATION; FEMALE; HODGKIN DISEASE; HORMONAL REGULATION; HUMAN; LAPAROSCOPIC SURGERY; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARIECTOMY; PRIORITY JOURNAL; RELAPSE;

EID: 67749088021     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.04.052     Document Type: Article

References (10)

1. Azem F., Samara N., Cohen T., Ben-Yosef D., Almog B., Lessing J.B., et al. Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease. J Assist Reprod Genet 25 (2008) 535-538
2. Blumenfeld Z., and von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14 (2008) 543-552
3. Oktay K., Sönmezer M., Oktem O., Fox K., Emons G., and Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12 (2007) 1055-1066
4. Oktay K., and Sönmezer M. Gonadotropin-releasing hormone analogs in fertility preservation-lack of biological basis?. Nat Clin Pract Endocrinol Metab 4 (2008) 488-489
5. Beck-Fruchter R., Weiss A., and Shalev E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14 (2008) 553-561
6. Fabbri R., Porcu E., Marsella T., Primavera M.R., Seracchioli R., Ciotti P.M., et al. Oocyte cryopreservation. Hum Reprod 13 (1998) 98-108
7. Newton H., Fisher J., Arnold J.R., Pegg D.E., Faddy M.J., and Gosden R.G. Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation. Hum Reprod 13 (1998) 376-380
8. Peters H., Bykov A.G., and Grinsted J. Follicular growth in fetal and prepubertal ovaries of humans and other primates. Clin Endocrinol Metab 7 (1978) 469-485
9. Zeleznik A.J. The physiology of follicle selection. Reprod Biol Endocrin 3 (2004) 31-37
10. Hughes E.H., and Neal M.S. Ovarian suppression to protect against chemotherapy-induced ovarian toxicity: helpful or just hopeful. Hum Reprod Update 14 (2008) 541-542